Mary Kay Ladone's most recent trade in Bioventus Inc - Ordinary Shares - Class A was a trade of 1,813 Class A Common Stock done . Disclosure was reported to the exchange on June 16, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bioventus Inc - Ordinary S... | Mary Kay Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 1,813 | 20,274 (0%) | 0% | 0 | Class A Common Stock | |
Bioventus Inc - Ordinary S... | Mary Kay Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 1,813 | 1,814 | - | - | Restricted Stock Units | |
Bioventus Inc - Ordinary S... | Mary Kay Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,400 | 30,400 | - | - | Restricted Stock Units | |
Bioventus Inc - Ordinary S... | Mary Kay Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 0 | - | - | Restricted Stock Units | |
Bioventus Inc - Ordinary S... | Mary Kay Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 18,461 (0%) | 0% | 0 | Class A Common Stock | |
Inogen Inc | Mary Kay Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 17,094 | 24,402 (0%) | 0% | 0 | Common Stock | |
Bioventus Inc - Ordinary S... | Mary Kay Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 16,648 | 16,648 | - | - | Restricted Stock Units | |
Bioventus Inc - Ordinary S... | Mary Kay Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 1,813 | 1,813 (0%) | 0% | 0 | Class A common stock | |
Bioventus Inc - Ordinary S... | Mary Kay Ladone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 1,813 | 3,627 | - | - | Restricted Stock Units | |
Inogen Inc | Mary Kay Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 6,849 | 7,308 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Mary Kay Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 459 | 459 (0%) | 0% | 0 | Common Stock | |
Bioventus Inc - Ordinary S... | Mary Kay Ladone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 5,440 | 5,440 | - | - | Restricted Stock Units |